Stress eating runs through the dopamine reward circuit cortisol activates, a different pathway GLP-1 does not reach cleanly
In a nationwide study in France, microvascular and macrovascular complications of diabetes mellitus were significantly associated with increased risk of mortality in patients with COVID-19 (ref
WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Effective concentration 25 % w/w (optimal ~5% w/w) Clinical evidence Real-world case series of 5% tranexamic acid serum demonstrated that application after in-office pigment-targeting procedures (non-ablative laser, microneedling, salicylic acid peel) may accelerate improvement in dyspigmentation
The evidence for energy, immunity and anti-ageing claims in well people is weak, so the value is mostly hydration, a short rest and the reassurance of a proper check first